Condition: Cardiopulmonary Bypass · Cardiac Surgery · Kidney Injury, Acute · Sponsor: University of Maryland, Baltimore
Studying the dynamics of red blood cell lysis, pfH, protective proteins and organ injury, limits will be set for safe levels of pfH following the use of CPB. These results will be compared to existing laboratory-based methods for determining red blood cell damage to predict CPB assist device safety. Further, results from the studies described in this proposal will help develop therapeutic strategies to benefit patients by early detection of pfH and clearance protein levels that occur during CPB.
This description comes directly from the study's public registry record.
Paul W Buehler, PhD · 14107065171 · pbuehler@som.umaryland.edu
Tobi Rowden, RN · 4107064061 · trowden@som.umaryland.edu
Always discuss trial participation with your own doctor first.
| Center for Blood Oxygen Transport and Hemostasis | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05189262